©The Author(s) 2025.
World J Diabetes. Nov 15, 2025; 16(11): 111223
Published online Nov 15, 2025. doi: 10.4239/wjd.v16.i11.111223
Published online Nov 15, 2025. doi: 10.4239/wjd.v16.i11.111223
Figure 4 Ribonucleotide reductase regulatory subunit M2 overexpression suppresses cellular reactive oxygen species production and oxidative stress in high glucose-treated renal tubular cells via the PI3K/Akt signaling pathway.
A: Representative images of dihydroergotamine (DHE) staining of HK-2 cells; B: Quantification of DHE-positive cells relative to DAPI-positive cells in the different groups; C-E: The colorimetric method was applied to analyze oxidative stress indicators in the lysate of HK-2 cells, and the levels of malondialdehyde (C), superoxide dismutase (D), and catalase (E) were measured. Data are presented as mean ± SD in triplicate and analyzed using one-way ANOVA. aP < 0.001 vs control group; bP < 0.001 vs high glucose (HG) group; cP < 0.001 vs HG + OE-ribonucleotide reductase regulatory subunit M2 group. HG: High glucose; OE-RRM2: Overexpressing ribonucleotide reductase regulatory subunit M2; DHE: Dihydroergotamine; MDA: Malondialdehyde; SOD: Superoxide dismutase; CAT: Catalase.
- Citation: Gao CC, Ding FF, Jiang X. RRM2 attenuates the renal tubular ferroptosis in diabetic kidney disease through PI3K/Akt/Nrf2 pathway. World J Diabetes 2025; 16(11): 111223
- URL: https://www.wjgnet.com/1948-9358/full/v16/i11/111223.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i11.111223